
### [MONDO:0002924](http://purl.obolibrary.org/obo/MONDO_0002924)
**Label:** smooth muscle cancer

**Subclasses:** [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), 

**Corr. equiv. classes:** [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), 

**Class expressions from DL-Learner:**

- [HP:0012268](http://purl.obolibrary.org/obo/HP_0012268) (Myxoid liposarcoma) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0012268](http://purl.obolibrary.org/obo/HP_0012268) (Myxoid liposarcoma) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0012268](http://purl.obolibrary.org/obo/HP_0012268) (Myxoid liposarcoma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) 75.00%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000956](http://purl.obolibrary.org/obo/HP_0000956) (Acanthosis nigricans))) 75.00%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 60.36%
- [HP:0012034](http://purl.obolibrary.org/obo/HP_0012034) (Liposarcoma) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 60.36%


